FDA Seeks to Remove Oral Phenylephrine From Decongestants

The US Food and Drug Administration (FDA) is considering removal of oral phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter (OTC) cold medications—including DayQuil, Theraflu, and Sudafed—after an extensive review of available data determined a lack of efficacy.

Authors

Publication Details

Journal
JAMA
Published
2024-12-20
DOI
https://doi.org/10.1001/jama.2024.25504
Primary Topic
Anesthesia and Sedative Agents
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA Seeks to Remove Oral Phenylephrine From Decongestants

Samantha Anderer
JAMA
Anesthesia and Sedative Agents
article

FDA Seeks to Remove Oral Phenylephrine From Decongestants

Samantha Anderer
article en

Abstract

The US Food and Drug Administration (FDA) is considering removal of oral phenylephrine, a widely used ingredient to treat nasal congestion, from over-the-counter (OTC) cold medications—including DayQuil, Theraflu, and Sudafed—after an extensive review of available data determined a lack of efficacy.

JAMAVol. 333(3)
Zero hunger
Openalex Percentile: Top 57%
Anesthesia and Sedative Agents
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA Seeks to Remove Oral Phenylephrine From Decongestants — Samantha Anderer · JAMA (2024) | TGRS Research Map | TGRS